Geographic exposure risk of variant Creutzfeldt-Jakob disease in US blood donors: a risk-ranking model to evaluate alternative donor-deferral policies-Reference-Cited by-同舟云学术

Geographic exposure risk of variant Creutzfeldt-Jakob disease in US blood donors: a risk-ranking model to evaluate alternative donor-deferral policies

Published:2017-03-05 Issue:4 Volume:57 Page:924-932
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:EDITORIAL

Author:

Yang Hong¹,Huang Yin¹,Gregori Luisa¹,Asher David M.¹,Bui Travis¹,Forshee Richard A.¹,Anderson Steven A.¹

Affiliation:

1. US Food and Drug Administration; Silver Spring Maryland

Funder

US Food and Drug Administration

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/trf.13971/fullpdf

Reference43 articles.

1. Creutzfeldt-Jakob disease and blood transfusion: results of the UK transfusion medicine epidemiological review study;Hewitt;Vox Sang,2006

2. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient;Peden;Lancet,2004

3. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion;Llewelyn;Lancet,2004

4. Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia;Peden;Haemophilia,2010

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modeling US blood donor deferrals under a policy of individual risk assessment for HIV risk sexual behavior;Transfusion;2024-06-12

2. Transmission of Variant Creutzfeldt-Jakob Disease Through Blood Transfusion and Plasma-Derived Products: A Narrative Review of Observed and Modeled Risks;Transfusion Medicine Reviews;2023-07

3. Editorial on the FDA Report on “Successes and Opportunities in Modeling & Simulation for FDA”;Annals of Biomedical Engineering;2022-12-22

4. Donor Screening and Deferral;Clinics in Laboratory Medicine;2021-12

5. Transfusion-transmitted infections;Annals of Blood;2021-01